SMTL ID : 6w06.1

Bruton's tyrosine kinase in complex with compound 6

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.55 Å

Oligo State

monomer

Ligands

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.1: 2 residues within 4Å: Chain A: T.37, F.38 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:F.38

1 x DTT: 2,3-DIHYDROXY-1,4-DITHIOBUTANE(Non-covalent)

DTT.2: 3 residues within 4Å: Chain A: C.115, L.117, R.159 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.159

1 x S5M: 4-~{tert}-butyl-~{N}-[[4-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]methyl]benzamide(Non-covalent)

S5M.3: 19 residues within 4Å: Chain A: L.42, G.45, Q.46, F.47, V.50, A.62, K.64, E.109, Y.110, M.111, G.114, D.155, N.160, L.162, D.173, L.176, S.177, V.180, Y.185 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.42, A:L.42, A:Q.46, A:F.47, A:F.47, A:V.50, A:V.50, A:D.155, A:L.176, A:V.180, A:Y.185 Hydrogen bonds: A:M.111, A:M.111 Water bridges: A:G.45, A:G.45

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ma, B. et al., Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases. J.Med.Chem. (2020)

Release Date

2020-12-16

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence